Once limited to hospital inpatient settings, total joint surgery is increasingly common at ambulatory surgery centers (ASCs) across the US. What is not so common is performing these complex procedures without the benefit of an onsite sterile processing department (SPD). And yet, that is exactly what we have accomplished at…

Read More

Editor's Note Glucagon-like peptide-1 (GLP-1) receptor agonists may offer orthopedic patients with obesity and type 2 diabetes a powerful tool for preoperative weight loss and potential disease modification, according to a July 10 review article in The Journal of Bone and Joint Surgery. However, the agents carry perioperative risks that…

Read More

Editor's Note According to a May 2025 Canadian Medical Association Journal study, creating centralized waitlists for hip and knee replacements can cut surgical wait times without increasing costs or expanding OR capacity, CBC News May 20 reports. The study, led by David Urbach, MD, MSC, head of the surgery department…

Read More

Editor's Note A recent Duke University analysis challenges the long‑held assumption that ambulatory surgery centers (ASCs) inherently deliver superior results for outpatient joint replacement, Orthopedics This Week March 18 reports. In the February 2025 Journal of Arthroplasty, researchers report that same‑day discharge total knee arthroplasty (TKA) performed in a tertiary‑care hospital…

Read More

Editor's Note Arthroplasty implants may release metals that accumulate in the central nervous system (CNS), potentially contributing to neurotoxic effects, according to a study published March 28 in JAMA Network Open. Researchers found that patients with large joint replacements had significantly higher levels of cobalt, chromium, titanium, niobium, and zirconium…

Read More

Editor's Note HST Pathways’ most recent industry report, discussed on the Advancing Surgical Care Podcast by HST CEO David Thawley and Bill Prentice, CEO of the Ambulatory Surgery Center Association (ASCA), offers insights into cardiology and orthopedic procedures done in ambulatory surgery centers (ASCs) in 2024, Ambulatory Surgery Center News…

Read More

Editor's Note The widespread adoption of GLP-1 weight-loss medications like Ozempic and Wegovy could put revenue at risk across multiple service lines, according to a March 11 article in Becker’s Hospital Review. As a result, hospitals and ambulatory surgery centers (ASCs) face critical questions about how to adapt. The article…

Read More

A wave of policy and regulatory changes is shaking up the healthcare industry—among many other markets. Like the COVID-19 pandemic greatly sped up the proliferation of ambulatory surgery centers (ASCs) by bringing traditional hospital operations to a standstill, ASCs are again on the poise of another boom. Medical innovation abounds…

Read More

Editor's Note In this panel at the 2025 OR Business Management Conference, led by Bob Winandy, MSN, MBA, RN, CEO of Brightside Surgical; Janet Carlson, MSN, BSN, RN, NE-BC, FACHE, executive director of ASCs at Commonwealth Pain & Spine; and Geri Eaves, BSN, RN, CASC, CNOR, CEO and administrator, The…

Read More

Stem cell therapy is poised to revolutionize regenerative medicine. As these therapies advance, they may alter or even replace certain invasive surgical procedures. Already undergoing advanced clinical trials, orthopedic applications are likely candidates for attracting the earliest adopters. Results so far indicate significant potential for providing alternatives to implants, grafts,…

Read More